PULSE DOSING VERSUS CONTINUOUS INFUSION OF ANTIBIOTICS - PHARMACOKINETIC-PHARMACODYNAMIC CONSIDERATIONS

被引：49
|
作者：
LEBEL, M
SPINO, M
机构：
[1] UNIV TORONTO,FAC PHARM,TORONTO M5S 1A1,ONTARIO,CANADA
[2] HOSP SICK CHILDREN,DIV CLIN PHARMACOL & TOXICOL,TORONTO M5G 1X8,ONTARIO,CANADA
来源：
CLINICAL PHARMACOKINETICS | 1988年 / 14卷 / 02期
关键词：
D O I：
10.2165/00003088-198814020-00002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：71 / 95
页数：25
相关论文
共 50 条
  • [31] Can pharmacokinetic-pharmacodynamic parameters provide dosing regimens that are less vulnerable to resistance?
    Courvalin, P.
    CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (11) : 989 - 994
  • [32] Selecting antibacterials for outpatient parenteral antimicrobial therapy - Pharmacokinetic-pharmacodynamic considerations
    Slavik, RS
    Jewesson, PJ
    CLINICAL PHARMACOKINETICS, 2003, 42 (09) : 793 - 817
  • [33] Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients
    Morales Junior, Ronaldo
    Telles, Joao Paulo
    Kwiatkowski, Shaina Ying-Ching
    Juodinis, Vanessa D'Amaro
    de Souza, Daniela Carla
    Cavani Jorge Santos, Silvia Regina
    LIVER TRANSPLANTATION, 2023, 29 (01) : 91 - 102
  • [34] Population pharmacokinetic-pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: Dosing considerations for Acinetobacter baumannii infections
    Yokoyama, Yuta
    Matsumoto, Kazuaki
    Ikawa, Kazuro
    Watanabe, Erika
    Morikawa, Norifumi
    Takeda, Yasuo
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (3-4) : 284 - 289
  • [35] Toward Model-Informed Precision Dosing for Remimazolam: A Population Pharmacokinetic-Pharmacodynamic Analysis
    Chen, Yueting
    Gong, Cansheng
    Liu, Feng
    Jiao, Zheng
    Zheng, Xiaochun
    PHARMACEUTICS, 2024, 16 (09)
  • [36] Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenalineinduced tachycardia as a continuous pharmacodynamic endpoint
    van Steeg, T. J.
    Freijer, J.
    Danhof, M.
    de Lange, E. C. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (03) : 356 - 366
  • [37] Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury
    Cota, Jason M.
    FakhriRavari, Alireza
    Rowan, Matthew P.
    Chung, Kevin K.
    Murray, Clinton K.
    Akers, Kevin S.
    CLINICAL THERAPEUTICS, 2016, 38 (09) : 2016 - 2031
  • [38] Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model
    Barr, J
    Egan, TD
    Sandoval, NF
    Zomorodi, K
    Cohane, C
    Gambus, PL
    Shafer, SL
    ANESTHESIOLOGY, 2001, 95 (02) : 324 - 333
  • [39] Can pharmacokinetic-pharmacodynamic parameters drive dosing regimens that are less vulnerable to resistance? Pro
    Novelli, A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S31 - S32
  • [40] Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model
    Zdovc, Jurij Aguiar
    Hanzel, Jurij
    Kurent, Tina
    Sever, Nejc
    Kozelj, Matic
    Smrekar, Natasa
    Novak, Gregor
    Stabuc, Borut
    Dreesen, Erwin
    Thomas, Debby
    Vovk, Tomaz
    Ostanek, Barbara
    Drobne, David
    Grabnar, Iztok
    PHARMACEUTICS, 2021, 13 (10)
12345